Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"
By
ecancer
FEATURING
Suresh Ramalingam
By
ecancer
FEATURING
Suresh Ramalingam
50 views
June 21, 2024
Login to view comments.
Click here to Login